US Patent 11833154 Methods of treatment of myeloproliferative neoplasm

Is a

Patent

Patent attributes

Patent Applicant

Memorial Sloan Kettering Cancer Center

Current Assignee

Memorial Sloan Kettering Cancer Center

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118331540

Patent Inventor Names

Anna Sophia McKenney0

Ross L. Levine0

Date of Patent

December 5, 2023

Patent Application Number

175535880

Date Filed

December 16, 2021

Patent Citations

‌

US Patent 9738625 Therapeutically active compounds and their methods of use

‌

US Patent 9751863 Therapeutically active compounds and their methods of use

‌

US Patent 9889137 Therapeutically active compounds and their methods of use

‌

US Patent 10093654 Therapeutically active compounds and their methods of use

‌

US Patent 10105369 Therapeutically active compounds and their methods of use

‌

US Patent 10111878 N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

‌

US Patent 10137130 Methods of treatment of malignancies

‌

US Patent 10188656 Methods of treatment of malignancies

...

Patent Primary Examiner

CPC Code

Patent abstract

Provided are methods and compositions for treating myeloproliferative neoplasms in patients carrying an IDH2 mutation and a JAK2 mutation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11833154 Methods of treatment of myeloproliferative neoplasm

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11833154 Methods of treatment of myeloproliferative neoplasm